Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol

<p>Abstract</p> <p>Background</p> <p>Major depressive disorder (MDD) is projected to rank second on a list of 15 major diseases in terms of burden in 2030. The major contribution of MDD to disability and health care costs is largely due to its highly recurrent nature. A...

Full description

Bibliographic Details
Main Authors: van Marwijk Harm, Schoevers Robert, van Valen Evelien, Smit Filip, Kamp Lillian, Kok Gemma D, Bockting Claudi LH, Cuijpers Pim, Riper Heleen, Dekker Jack, Beck Aaron T
Format: Article
Language:English
Published: BMC 2011-01-01
Series:BMC Psychiatry
Online Access:http://www.biomedcentral.com/1471-244X/11/12
_version_ 1818580649529835520
author van Marwijk Harm
Schoevers Robert
van Valen Evelien
Smit Filip
Kamp Lillian
Kok Gemma D
Bockting Claudi LH
Cuijpers Pim
Riper Heleen
Dekker Jack
Beck Aaron T
author_facet van Marwijk Harm
Schoevers Robert
van Valen Evelien
Smit Filip
Kamp Lillian
Kok Gemma D
Bockting Claudi LH
Cuijpers Pim
Riper Heleen
Dekker Jack
Beck Aaron T
author_sort van Marwijk Harm
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Major depressive disorder (MDD) is projected to rank second on a list of 15 major diseases in terms of burden in 2030. The major contribution of MDD to disability and health care costs is largely due to its highly recurrent nature. Accordingly, efforts to reduce the disabling effects of this chronic condition should shift to preventing recurrence, especially in patients at high risk of recurrence. Given its high prevalence and the fact that interventions are necessary during the remitted phase, new approaches are needed to prevent relapse in depression.</p> <p>Methods/design</p> <p>The best established effective and available psychological intervention is cognitive therapy. However, it is costly and not available for most patients. Therefore, we will compare the effectiveness and cost-effectiveness of self-management supported by online CT accompanied by SMS based tele-monitoring of depressive symptomatology, i.e. Mobile Cognitive Therapy (M-CT) versus treatment as us usual (TAU). Remitted patients (n = 268) with at least two previous depressive episodes will be recruited and randomized over (1) M-CT in addition to TAU versus (2) TAU alone, with follow-ups at 3, 12, and 24 months. Randomization will be stratified for number of previous episodes and type of treatment as usual. Primary outcome is time until relapse/recurrence over 24 months using DSM-IV-TR criteria as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). For the economic evaluation the balance between costs and health outcomes will be compared across strategies using a societal perspective.</p> <p>Discussion</p> <p>Internet-based interventions might be helpful in empowering patients to become their own disease managers in this lifelong recurrent disorder. This is, as far as we are aware of, the first study that examines the (cost) effectiveness of an E-mental health program using SMS monitoring of symptoms with therapist support to prevent relapse in remitted recurrently depressed patients.</p> <p>Trial registration</p> <p>Netherlands Trial Register (NTR): <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2503">NTR2503</a></p>
first_indexed 2024-12-16T07:20:57Z
format Article
id doaj.art-c8506e8e623a48119f83b50d5c9f429f
institution Directory Open Access Journal
issn 1471-244X
language English
last_indexed 2024-12-16T07:20:57Z
publishDate 2011-01-01
publisher BMC
record_format Article
series BMC Psychiatry
spelling doaj.art-c8506e8e623a48119f83b50d5c9f429f2022-12-21T22:39:39ZengBMCBMC Psychiatry1471-244X2011-01-011111210.1186/1471-244X-11-12Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocolvan Marwijk HarmSchoevers Robertvan Valen EvelienSmit FilipKamp LillianKok Gemma DBockting Claudi LHCuijpers PimRiper HeleenDekker JackBeck Aaron T<p>Abstract</p> <p>Background</p> <p>Major depressive disorder (MDD) is projected to rank second on a list of 15 major diseases in terms of burden in 2030. The major contribution of MDD to disability and health care costs is largely due to its highly recurrent nature. Accordingly, efforts to reduce the disabling effects of this chronic condition should shift to preventing recurrence, especially in patients at high risk of recurrence. Given its high prevalence and the fact that interventions are necessary during the remitted phase, new approaches are needed to prevent relapse in depression.</p> <p>Methods/design</p> <p>The best established effective and available psychological intervention is cognitive therapy. However, it is costly and not available for most patients. Therefore, we will compare the effectiveness and cost-effectiveness of self-management supported by online CT accompanied by SMS based tele-monitoring of depressive symptomatology, i.e. Mobile Cognitive Therapy (M-CT) versus treatment as us usual (TAU). Remitted patients (n = 268) with at least two previous depressive episodes will be recruited and randomized over (1) M-CT in addition to TAU versus (2) TAU alone, with follow-ups at 3, 12, and 24 months. Randomization will be stratified for number of previous episodes and type of treatment as usual. Primary outcome is time until relapse/recurrence over 24 months using DSM-IV-TR criteria as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). For the economic evaluation the balance between costs and health outcomes will be compared across strategies using a societal perspective.</p> <p>Discussion</p> <p>Internet-based interventions might be helpful in empowering patients to become their own disease managers in this lifelong recurrent disorder. This is, as far as we are aware of, the first study that examines the (cost) effectiveness of an E-mental health program using SMS monitoring of symptoms with therapist support to prevent relapse in remitted recurrently depressed patients.</p> <p>Trial registration</p> <p>Netherlands Trial Register (NTR): <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2503">NTR2503</a></p>http://www.biomedcentral.com/1471-244X/11/12
spellingShingle van Marwijk Harm
Schoevers Robert
van Valen Evelien
Smit Filip
Kamp Lillian
Kok Gemma D
Bockting Claudi LH
Cuijpers Pim
Riper Heleen
Dekker Jack
Beck Aaron T
Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol
BMC Psychiatry
title Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol
title_full Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol
title_fullStr Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol
title_full_unstemmed Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol
title_short Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol
title_sort disrupting the rhythm of depression using mobile cognitive therapy for recurrent depression randomized controlled trial design and protocol
url http://www.biomedcentral.com/1471-244X/11/12
work_keys_str_mv AT vanmarwijkharm disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT schoeversrobert disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT vanvalenevelien disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT smitfilip disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT kamplillian disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT kokgemmad disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT bocktingclaudilh disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT cuijperspim disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT riperheleen disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT dekkerjack disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol
AT beckaaront disruptingtherhythmofdepressionusingmobilecognitivetherapyforrecurrentdepressionrandomizedcontrolledtrialdesignandprotocol